Clinical trials in systemic lupus erythematosus: the dilemma—Why have phase III trials failed to confirm the promising results of phase II trials?
Ana Lorenzo-Vizcaya, David Isenberg
Topics & Concepts
MedicineClinical trialRituximabImmunologyInternal medicineAntibodySystemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies ResearchLymphoma Diagnosis and Treatment